Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adagio Medical Holdings (ADGM) Free Cash Flow (2023 - 2026)

Adagio Medical Holdings has reported Free Cash Flow over the past 4 years, most recently at -$4.1 million for Q1 2026.

  • Quarterly Free Cash Flow rose 45.56% to -$4.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$7.7 million through Mar 2026, up 63.1% year-over-year, with the annual reading at -$19.4 million for FY2025, 31.45% down from the prior year.
  • Free Cash Flow was -$4.1 million for Q1 2026 at Adagio Medical Holdings, down from -$3.6 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at -$3.6 million in Q4 2025 and troughed at -$7.5 million in Q1 2025.
  • The 4-year median for Free Cash Flow is -$6.8 million (2023), against an average of -$6.1 million.
  • Year-over-year, Free Cash Flow fell 9.81% in 2025 and then surged 45.56% in 2026.
  • A 4-year view of Free Cash Flow shows it stood at -$6.8 million in 2023, then fell by 2.84% to -$7.0 million in 2024, then soared by 47.74% to -$3.6 million in 2025, then decreased by 12.48% to -$4.1 million in 2026.
  • Per Business Quant, the three most recent readings for ADGM's Free Cash Flow are -$4.1 million (Q1 2026), -$3.6 million (Q4 2025), and -$7.5 million (Q1 2025).